302 related articles for article (PubMed ID: 30149443)
1. Colocalization of Aluminum and Iron in Nuclei of Nerve Cells in Brains of Patients with Alzheimer's Disease.
Yumoto S; Kakimi S; Ishikawa A
J Alzheimers Dis; 2018; 65(4):1267-1281. PubMed ID: 30149443
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease.
Yumoto S; Kakimi S; Ohsaki A; Ishikawa A
J Inorg Biochem; 2009 Nov; 103(11):1579-84. PubMed ID: 19744735
[TBL] [Abstract][Full Text] [Related]
3. Glial cells contribute more to iron and aluminum accumulation but are more resistant to oxidative stress than neuronal cells.
Oshiro S; Kawahara M; Kuroda Y; Zhang C; Cai Y; Kitajima S; Shirao M
Biochim Biophys Acta; 2000 Nov; 1502(3):405-14. PubMed ID: 11068183
[TBL] [Abstract][Full Text] [Related]
4. A laser microprobe mass analysis of brain aluminum and iron in dementia pugilistica: comparison with Alzheimer's disease.
Bouras C; Giannakopoulos P; Good PF; Hsu A; Hof PR; Perl DP
Eur Neurol; 1997; 38(1):53-8. PubMed ID: 9252800
[TBL] [Abstract][Full Text] [Related]
5. A reexamination of aluminum in Alzheimer's disease: analysis by energy dispersive X-ray microprobe and flameless atomic absorption spectrophotometry.
Jacobs RW; Duong T; Jones RE; Trapp GA; Scheibel AB
Can J Neurol Sci; 1989 Nov; 16(4 Suppl):498-503. PubMed ID: 2804812
[TBL] [Abstract][Full Text] [Related]
6. A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease.
Shin RW; Kruck TP; Murayama H; Kitamoto T
Brain Res; 2003 Jan; 961(1):139-46. PubMed ID: 12535786
[TBL] [Abstract][Full Text] [Related]
7. Aluminum in hippocampal neurons from humans with Alzheimer's disease.
Walton JR
Neurotoxicology; 2006 May; 27(3):385-94. PubMed ID: 16458972
[TBL] [Abstract][Full Text] [Related]
8. Exploring valence states of abnormal mineral deposits in biological tissues using correlative microscopy and spectroscopy techniques: A case study on ferritin and iron deposits from Alzheimer's disease patients.
Zeng Y; DiGiacomo PS; Madsen SJ; Zeineh MM; Sinclair R
Ultramicroscopy; 2021 Dec; 231():113254. PubMed ID: 33781589
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
10. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
[TBL] [Abstract][Full Text] [Related]
11. Aluminum and copper interact in the promotion of oxidative but not inflammatory events: implications for Alzheimer's disease.
Becaria A; Bondy SC; Campbell A
J Alzheimers Dis; 2003 Feb; 5(1):31-8. PubMed ID: 12590164
[TBL] [Abstract][Full Text] [Related]
12. Scavenger receptor class B type I expression and elemental analysis in cerebellum and parietal cortex regions of the Alzheimer's disease brain.
Srivastava RA; Jain JC
J Neurol Sci; 2002 Apr; 196(1-2):45-52. PubMed ID: 11959156
[TBL] [Abstract][Full Text] [Related]
13. The role of transition metals in the pathogenesis of Parkinson's disease.
Kienzl E; Puchinger L; Jellinger K; Linert W; Stachelberger H; Jameson RF
J Neurol Sci; 1995 Dec; 134 Suppl():69-78. PubMed ID: 8847547
[TBL] [Abstract][Full Text] [Related]
14. Laser microprobe analysis of brain aluminum in Alzheimer's disease.
Lovell MA; Ehmann WD; Markesbery WR
Ann Neurol; 1993 Jan; 33(1):36-42. PubMed ID: 8257483
[TBL] [Abstract][Full Text] [Related]
15. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer's disease brain.
Kuhla A; Ludwig SC; Kuhla B; Münch G; Vollmar B
Neurobiol Aging; 2015 Feb; 36(2):753-61. PubMed ID: 25448604
[TBL] [Abstract][Full Text] [Related]
17. Correlative Microscopy to Localize and Characterize Iron Deposition in Alzheimer's Disease.
Madsen SJ; DiGiacomo PS; Zeng Y; Goubran M; Chen Y; Rutt BK; Born D; Vogel H; Sinclair R; Zeineh MM
J Alzheimers Dis Rep; 2020 Dec; 4(1):525-536. PubMed ID: 33532700
[TBL] [Abstract][Full Text] [Related]
18. Deferoxamine ameliorated Al(mal)
Zhu D; Liang R; Liu Y; Li Z; Cheng L; Ren J; Guo Y; Wang M; Chai H; Niu Q; Yang S; Bai J; Yu H; Zhang H; Qin X
Toxicol Mech Methods; 2022 Sep; 32(7):530-541. PubMed ID: 35313783
[TBL] [Abstract][Full Text] [Related]
19. Aluminum and Alzheimer's Disease.
Colomina MT; Peris-Sampedro F
Adv Neurobiol; 2017; 18():183-197. PubMed ID: 28889268
[TBL] [Abstract][Full Text] [Related]
20. Immunostaining of calmodulin and aluminium in Alzheimer's disease-affected brains.
Solomon B; Koppel R; Jossiphov J
Brain Res Bull; 2001 May; 55(2):253-6. PubMed ID: 11470324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
